Accelerant (ARX) Co-founder, CEO Jeffrey Radke Sells $1M of Stock

Insider Buying and Selling at Accelerant Holdings

Jeffrey Radke, Co-Founder and CEO of Accelerant Holdings (NYSE: ARX), sold 80,000 shares on June 29, 2026, for about $1,029,600 at a price of $12.87 each. This was a planned transaction, and the stock closed at $11.72 on the reporting day, significantly lower than its prior close of $19.66.

Recent Insider Activity

Radke’s sale follows a pattern of insider transactions at Accelerant Holdings. Just a few days earlier, Oneill Francis James, Co-Founder and Chief Underwriting Officer, sold 73,500 shares on June 26, 2026, valued at around $968,730. Prior to that, James also sold 76,464 shares on June 23, 2026, worth over $1 million. These recent sales suggest a trend among the company’s leadership to liquidate some holdings.

How Accelerant Holdings Stock Has Traded

The stock price of Accelerant Holdings has been volatile, trading well below its 52-week high of $19.90. It has also dipped from its 50-day moving average of $16.62, which could signal shifting investor sentiment. The company’s market cap stands at about $4.3 billion, and investors will be watching closely to see how the stock reacts to insider selling and upcoming earnings.

Analysts Set New Price Targets

Several analysts have recently downgraded their ratings for Accelerant Holdings. On September 30, 2026, TD Cowen downgraded the stock to a Hold rating with a price target of $20.25, down from $30.00. Raymond James rated it Underperform on September 23, while Citizens and William Blair also downgraded their ratings to Market Perform in August. Despite these downgrades, Wells Fargo has maintained an Overweight rating with a target of $16.00, suggesting mixed views on the company's future performance.

What Accelerant Holdings Does

Accelerant Holdings operates a data-driven risk exchange that connects specialized insurance underwriters with capital partners. This model focuses on serving small to medium-sized commercial clients across various regions, including the U.S. and Europe. The recent insider sales could reflect the company's ongoing adjustments as it continues navigating the insurance market.

What’s Next for Accelerant Holdings

Investors should keep an eye on the upcoming earnings report scheduled for November 11, 2026. The recent 13F filings and insider transactions provide insights, but it's important to note that these filings reflect past positions and may not represent current holdings. As the company approaches its earnings date, market reactions to insider selling will be crucial.